Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis
Author:
Affiliation:
1. Division of endocrinology, Department of Internal Medicine; Seoul National University College of Medicine; Seoul South Korea
2. Medical Research Collaborating Center; Seoul National University Hospital; Seoul South Korea
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12293/fullpdf
Reference51 articles.
1. Diabetes in Asia: epidemiology, risk factors, and pathophysiology;Chan;JAMA,2009
2. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis;Kodama;Diabetes Care,2013
3. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis;Kim;Diabetologia,2013
4. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety;Deacon;Expert Opin Pharmacother,2013
5. Targeting the glucagon receptor family for diabetes and obesity therapy;Cho;Pharmacol Ther,2012
Cited by 144 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study;2024-09-09
2. Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study;Journal of Diabetes & Metabolic Disorders;2024-07-26
3. Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials;Journal of Clinical Lipidology;2024-07
4. Clinical efficacy and cost‐effectiveness of metformin in different patient populations: A narrative review of real‐world evidence;Diabetes, Obesity and Metabolism;2024-06-28
5. The integrated incretin effect is reduced by both glucose intolerance and obesity in Japanese subjects;Frontiers in Endocrinology;2024-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3